drugset / Trial / NCT00539071
High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone
Phase 4
Completed
160 enrolled
Northwestern University
Ortho-McNeil Janssen Scientific Affairs, LLC · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to look at two doses of long-acting injectable risperidone (Risperdal Consta). The study will use a usual dose of Risperdal Consta (50 mg given every two weeks) or a higher dose (75 mg-100 mg given every two weeks) to see which one is better at improving symptoms of schizophrenia or schizoaffective disorder.
Timeline
- Start
- 2008-03
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Risperidone | Other / unclassified | 50 mg | Other |
| Comparator | Risperidone | Other / unclassified | 75 mg | Other |
| Comparator | Risperidone | Other / unclassified | 100 mg | Other |